One of the biggest advantages of the new polymer-based nanoparticles over current lipid-based models is the potential for low-tech, decentralized production. Hossainy says he imagines being able to ...

When the COVID-19 pandemic swept across the world in 2020, the mRNA vaccines came to the rescue of many people—but in the background there was another, lesser known, hero: the lipid nanoparticle.

A new technique lets researchers make many more of the particles much faster, using consistent practices that meet safety standards. Over the past decade, Institute Professor Paula Hammond ’84, PhD ...